可药性
信号转导
癌症研究
生物
化学
细胞生物学
抑制器
癌症
疾病
医学
细胞信号
作者
Mengmeng Wang,Shuangwei Liu,Lei Xu,Weiteng Cao,Xinyue Wang,Yubo Wang,Yanshuo Cheng,Ning Liu,Ziqi Huang,Kun Zhang,Ranlu Liu,Lan Ma,Cheng Yang,Guang Yang
标识
DOI:10.1016/j.xcrm.2026.103169
摘要
Single-cell RNA sequencing, bulk RNA sequencing, and retrospective analyses of patient specimens identify exportin 5 (XPO5), a nuclear export receptor, as a key contributor to advanced prostate cancer (PCa) progression. Microphthalmia-associated transcription factor (MITF) activates transcription of acyl-CoA synthetase long-chain family member 4 (ACSL4). XPO5 promotes MITF nuclear export, suppresses ACSL4 transcription, and confers resistance to ferroptosis. Differential-scanning-fluorimetry-based high-throughput screening identifies 2-B8 as a molecular glue degrader of XPO5. 2-B8 covalently binds XPO5 at Cys1157 and recruits the TMEM33-RNF5 E3 ubiquitin ligase complex, promoting XPO5 ubiquitination and degradation. In cellular, cell-derived xenograft, and patient-derived xenograft models, 2-B8 induces ferroptosis, suppresses tumor growth, and enhances chemosensitivity. These findings establish the XPO5-MITF-ACSL4 axis as a mechanism of ferroptosis resistance and support targeting XPO5 for the treatment of advanced PCa.
科研通智能强力驱动
Strongly Powered by AbleSci AI